| 中文名称 | 4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) |
|---|---|
| 中文同义词 | |
| 英文名称 | 4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) |
| 英文同义词 | 4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1);TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride;1-(4-(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-8-yl)piperazin-1-yl)-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oic acid hydrochloride |
| CAS号 | 2388520-36-1 |
| 分子式 | C41H69ClN6O12 |
| 分子量 | 873.48 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 2388520-36-1.mol |
| 结构式 | ![]() |
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) 性质
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) 用途与合成方法
TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride (compound 9) 是抗体-活性分子偶联物的一部分,由 TLR7/8 激活剂 TLR7/8 agonist 4 (HY-139018) 和可降解的 ADC linker hydroxy-PEG10-acid (HY-133307) 连接而成。
![4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) 结构式](CAS/20211123/GIF/2388520-36-1.gif)